DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 64 filers reported holding DERMA SCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,385,000 | +12.8% | 843,287 | +1.3% | 0.00% | – |
| Q3 2016 | $3,886,000 | +22.9% | 832,154 | +3.6% | 0.00% | – |
| Q2 2016 | $3,163,000 | +28.4% | 802,878 | +1.1% | 0.00% | – |
| Q1 2016 | $2,463,000 | -20.8% | 794,502 | +16.7% | 0.00% | – |
| Q4 2015 | $3,111,000 | -98.1% | 680,755 | -87.8% | 0.00% | -100.0% |
| Q3 2015 | $159,945,000 | +3871.8% | 5,583,848 | +892.9% | 0.01% | – |
| Q2 2015 | $4,027,000 | -18.4% | 562,397 | -3.5% | 0.00% | – |
| Q1 2015 | $4,938,000 | -2.4% | 582,976 | +7.2% | 0.00% | – |
| Q4 2014 | $5,061,000 | +14.9% | 543,641 | +2.8% | 0.00% | – |
| Q3 2014 | $4,406,000 | -23.7% | 528,997 | +5.8% | 0.00% | – |
| Q2 2014 | $5,778,000 | -7.7% | 499,861 | +1.3% | 0.00% | -100.0% |
| Q1 2014 | $6,257,000 | +103.7% | 493,425 | +73.8% | 0.00% | – |
| Q4 2013 | $3,072,000 | -5.7% | 283,976 | +7.9% | 0.00% | – |
| Q3 2013 | $3,258,000 | -0.6% | 263,171 | +7.2% | 0.00% | – |
| Q2 2013 | $3,279,000 | – | 245,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |